These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1466949)
1. The next steps in HIV vaccine development. Ada G; Koff W; Petricciani J AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1317-9. PubMed ID: 1466949 [No Abstract] [Full Text] [Related]
2. Prospects for vaccine protection against HIV-1 infection and AIDS. Letvin NL; Barouch DH; Montefiori DC Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598 [TBL] [Abstract][Full Text] [Related]
4. Humoral immunity to HIV, SIV, and SHIV. Haigwood NL; Zolla-Pazner S AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993 [No Abstract] [Full Text] [Related]
5. Primate models of AIDS vaccine development. Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975 [No Abstract] [Full Text] [Related]
6. AIDS vaccine development in primate models. Almond NM; Heeney JL AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994 [No Abstract] [Full Text] [Related]
7. HIV vaccination dilemma. Sabin AB Nature; 1993 Mar; 362(6417):212. PubMed ID: 8318105 [No Abstract] [Full Text] [Related]
8. CTL ontogeny and viral escape: implications for HIV-1 vaccine design. Yang OO Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041 [No Abstract] [Full Text] [Related]
9. Search for AIDS vaccine advances. Hum Vaccin Immunother; 2012 Feb; 8(2):151. PubMed ID: 22745942 [No Abstract] [Full Text] [Related]
10. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies. Warren JT; Dolatshahi M J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110 [No Abstract] [Full Text] [Related]
11. Antibodies and resistance to natural HIV infection. Nabel GJ; Sullivan NJ N Engl J Med; 2000 Oct; 343(17):1263-5. PubMed ID: 11071680 [No Abstract] [Full Text] [Related]